Acute Viral Conjunctivitis Author: Stephen Orlin, MD
Module updated - 2008-04-08
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Patient Education
  • Advise patients that acute viral conjunctivitis is highly contagious.
  • Inform patients about other potentially sight-threatening causes of conjunctivitis.


Advise patients that acute viral conjunctivitis is highly contagious. C

  • Advise patients to remain out of school, work, or daycare for 5 to 7 days or until the eye is no longer red and tearing.
  • Advise patients to:
    • Wash hands frequently
    • Avoid sharing face cloths, towels, bed linens, and makeup with close contacts
    • Avoid contact lenses in the acute phase of disease
    • Avoid personal contact with others until symptoms have subsided
  • Reassure patients about the self-limiting nature of the disease.
  • Recommend that patients use dilute bleach to clean common areas at home such as refrigerator door handles, remote controls, and phones.
Background | Back to top


Inform patients about other potentially sight-threatening causes of conjunctivitis. C

  • Advise patients to promptly contact a physician in the event of:
    • Chronicity
    • Blurred vision
    • Ocular pain
    • Fever
    • Genitourinary discharge
    • Shortness of breath
    • Skin rashes
    • Allergies
Background | Back to top

FAQs
Robert Sambursky, MD, editorial consultant, Chief Medical Officer for Rapid Pathogen Screening, Inc.;served as consultant for Rapid Pathogen Screening, Inc.;received an honoraria for Rapid Pathogen Screening, Inc.;serves as consultant for Rapid Pathogen Screening, Inc; owns stock options in Rapid Pathogen Screening, Inc.;served as board member or director for Rapid Pathogen Screening, Inc.;received grants and has grants pending from Rapid Pathogen Screening, Inc.;and has received patents and has patents pending for Rapid Pathogen Screening, Inc. Stephen Orlin, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.